Clinical Trial Update: Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is recruiting to evaluate xenon inhalation therapy for major depressive disorder and bipolar disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Drugs mentioned

• Xenon inhalation therapy (xenon)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Major Depressive Disorder, Bipolar Depression | EARLY_Phase 1 | Status: RECRUITING